Prescription medicine use by pedestrians and the risk of injurious road traffic crashes: A case-crossover study

1. Constant A, Lagarde E. Protecting vulnerable road users from injury. PLOS Med. 2010;7:e1000228. doi: 10.1371/journal.pmed.1000228 20361017

2. World Health Organization. Global status report on road safety 2013. http://www.who.int/violence_injury_prevention/road_safety_status/2013/en/. Accessed 2015 Aug 26.

3. Asher L, Aresu M, Falaschetti E, Mindell J. Most older pedestrians are unable to cross the road in time: a cross-sectional study. Age Ageing. 2012;41:690–4. doi: 10.1093/ageing/afs076 22695790

4. Sze NN, Wong SC. Diagnostic analysis of the logistic model for pedestrian injury severity in traffic crashes. Accid Anal Prev. 2007;39:1267–78. doi: 10.1016/j.aap.2007.03.017 17920851

5. Mueller BA, Rivara FP, Bergman AB. Factors associated with pedestrian-vehicle collision injuries and fatalities. West J Med. 1987;146:243–5. 3825131

6. Aziz HMA, Ukkusuri SV, Hasan S. Exploring the determinants of pedestrian–vehicle crash severity in New York City. Accid Anal Prev. 2013;50:1298–309. doi: 10.1016/j.aap.2012.09.034 23122781

7. Dai D. Identifying clusters and risk factors of injuries in pedestrian vehicle crashes in a GIS environment. J Transp Geogr. 2012;24:206–14. doi: 10.1016/j.jtrangeo.2012.02.005

8. Gårder PE. The impact of speed and other variables on pedestrian safety in Maine. Accid Anal Prev. 2004;36:533–42. doi: 10.1016/S0001-4575(03)00059-9 15094405

9. Kurzthaler I, Wambacher M, Golser K, Sperner G, Sperner-Unterweger B, Haidekker A, et al. Alcohol and/or benzodiazepine use: different accidents—different impacts? Hum Psychopharmacol. 2005;20:583–9. doi: 10.1002/hup.736 16317801

10. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992;136:873–83. 1442753

11. Movig KLL, Mathijssen MPM, Nagel PHA, Van Egmond T, de Gier JJ, Leufkens HGM, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev. 2004;36:631–6. doi: 10.1016/S0001-4575(03)00084-8 15094417

12. Orriols L, Philip P, Moore N, Castot A, Gadegbeku B, Delorme B, et al. Benzodiazepine-like hypnotics and the associated risk of road traffic accidents. Clin Pharmacol Ther. 2011;89:595–601. doi: 10.1038/clpt.2011.3 21368756

13. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology. 1994;5:591–8. 7841240

14. Fournier JP, Wilchesky M, Patenaude V, Suissa S. Concurrent use of benzodiazepines and antidepressants and the risk of motor vehicle accident in older drivers: a nested case–control study. Neurol Ther. 2015;4:39–51. doi: 10.1007/s40120-015-0026-0 26847674

15. Orriols L, Wilchesky M, Lagarde E, Suissa S. Prescription of antidepressants and the risk of road traffic crash in the elderly: a case–crossover study. Br J Clin Pharmacol. 2013;76:810–5. doi: 10.1111/bcp.12090 24148104

16. Rapoport MJ, Zagorski B, Seitz D, Herrmann N, Molnar F, Redelmeier DA. At-fault motor vehicle crash risk in elderly patients treated with antidepressants. Am J Geriatr Psychiatry. 2011;19:998–1006. doi: 10.1097/JGP.0b013e31820d93f9 22123273

17. Orriols L, Queinec R, Philip P, Gadegbeku B, Delorme B, Moore N, et al. Risk of injurious road traffic crash after prescription of antidepressants. J Clin Psychiatry. 2012;73:1088–94. doi: 10.4088/JCP.11m07624 22967773

18. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev. 2004;36:239–48. 14642878

19. Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med. 2013;173:196–201. doi: 10.1001/2013.jamainternmed.733 23318919

20. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007;17:597–602. doi: 10.1016/j.annepidem.2007.03.009 17574863

21. McGwin G, Sims RV, Pulley L, Roseman JM. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol. 2000;152:424–31. doi: 10.1093/aje/152.5.424 10981455

22. Elliott S, Woolacott H, Braithwaite R. The prevalence of drugs and alcohol found in road traffic fatalities: a comparative study of victims. Sci Justice. 2009;49:19–23. doi: 10.1016/j.scijus.2008.06.001 19418924

23. Australian Department of Infrastructure and Regional Development. Monograph 14—male pedestrian fatalities. http://www.infrastructure.gov.au/roads/safety/publications/2003/Ped_Male_1.aspx. Accessed 2015 Mar 3.

24. Orriols L, Delorme B, Gadegbeku B, Tricotel A, Contrand B, Laumon B, et al. Prescription medicines and the risk of road traffic crashes: a French registry-based study. PLOS Med. 2010;7:e1000366. doi: 10.1371/journal.pmed.1000366 21125020

25. Trouessin G, Allaert FA. FOIN: a nominative information occultation function. Stud Health Technol Inform. 1997;4(Pt A):196–200.

26. Riché C, Caulin C, Caron J, Chiffoleau A, Corbé C, Diquet B, et al. Medicinal products and driving. March 2009 update. Paris: Agence Nationale de Sécurité du Médicament et des Produits de Santé; 2009. http://ansm.sante.fr/var/ansm_site/storage/original/application/e5f2e48d5344bcfef6ca865ac63e7c3d.pdf. Accessed 2017 Jun 13.

27. Agence Française de Sécurité Sanitaire des Produits de Santé. Mise au point: Médicaments et conduite automobile. Paris: Agence Nationale de Sécurité du Médicament et des Produits de Santé; 2009. http://ansm.sante.fr/var/ansm_site/storage/original/application/faff1e402339cd443a9894792f20d31d.pdf. Accessed 2017 Jun 13.

28. IMS Health. Enquête Permanente sur la Prescription Médicale (EPPM). Danbury (Connecticut): IMS Health; 2005–2011.

29. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health. 2000;21:193–221. doi: 10.1146/annurev.publhealth.21.1.193 10884952

30. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol. 1996;58:267–88.

31. Bach F. Bolasso: model consistent Lasso estimation through the bootstrap. Ithaca (New York): arXiv.org; 2008. arXiv.0804.1302. http://arxiv.org/abs/0804.1302. Accessed 2017 Jun 13.

32. Avalos M, Orriols L, Pouyes H, Grandvalet Y, Thiessard F, Lagarde E, et al. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes. Pharmacoepidemiol Drug Saf. 2014;23:140–51. doi: 10.1002/pds.3539 24136855

33. Belloni A, Chernozhukov V. Least squares after model selection in high-dimensional sparse models. Bernoulli. 2013;19:521–47. doi: 10.3150/11-BEJ410

34. Loo BPY, Tsui KL. Pedestrian injuries in an ageing society: insights from hospital trauma registry. J Trauma. 2009;66:1196–201. doi: 10.1097/TA.0b013e31817fdef6 19359937

35. Noize P, Bazin F, Dufouil C, Lechevallier-Michel N, Ancelin M-L, Dartigues J-F, et al. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf. 2009;18:310–9. doi: 10.1002/pds.1717 19241438

36. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133:144–53. 1985444

37. Mittleman MA, Mostofsky E. Exchangeability in the case-crossover design. Int J Epidemiol. 2014;43:1645–55. doi: 10.1093/ije/dyu081 24756878

38. Orriols L, Luxcey A, Contrand B, Gadegbeku B, Delorme B, Tricotel A, et al. Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility study. Br J Clin Pharmacol. 2016;82:1625–35. doi: 10.1111/bcp.13075 27544927

39. Öström M, Eriksson A. Pedestrian fatalities and alcohol. Accid Anal Prev. 2001;33:173–80. doi: 10.1016/S0001-4575(00)00028-2 11204887

40. L’Observatoire National Interministériel de la Sécurité Routière. Données brutes. http://www.securite-routiere.gouv.fr/la-securite-routiere/l-observatoire-national-interministeriel-de-la-securite-routiere/series-statistiques/donnees-brutes. Accessed 2017 Feb 7.

41. Bird ST, Delaney JAC, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40–85 years in the United States: risk window analyses using between and within patient methodology. BMJ. 2013;347:f6320. doi: 10.1136/bmj.f6320 24192967

42. Chrischilles E, Rubenstein L, Chao J, Kreder KJ, Gilden D, Shah H. Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. Clin Ther. 2001;23:727–43. doi: 10.1016/S0149-2918(01)80022-9 11394731

43. Oelke M, Gericke A, Michel MC. Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms. Expert Opin Drug Saf. 2014;13:1187–97. doi: 10.1517/14740338.2014.936376 25073735

44. Geller EJ, Crane AK, Wells EC, Robinson BL, Jannelli ML, Khandelwal CM, et al. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in post-menopausal women. Clin Drug Investig. 2012;32:697–705. 22873491

45. Munjuluri N, Wong W, Yoong W. Anticholinergic drugs for overactive bladder: a review of the literature and practical guide. Obstet Gynaecol. 2007;9:9–14. doi: 10.1576/toag.9.1.009.27290

46. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997;157:1681–6. doi: 10.1001/archinte.1997.00440360095010 9250229

47. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22:99–111. 10333910

48. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med. 1991;8:217–22. 1828735

49. Sommerfield AJ, Deary IJ, McAulay V, Frier BM. Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care. 2003;26:390–6. 12547868

50. Brands AMA, Biessels GJ, de Haan EHF, Kappelle LJ, Kessels RPC. The effects of type 1 diabetes on cognitive performance a meta-analysis. Diabetes Care. 2005;28:726–35. 15735218

51. Colás C, Galera H, Añibarro B, Soler R, Navarro A, Jáuregui I, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy. 2012;42:1080–7. doi: 10.1111/j.1365-2222.2011.03935.x 22251258

52. Muliol J, Maurer M, Bousquet J. Sleep and allergic rhinitis. J Investig Allergol Clin Immunol. 2008;18:415–9. 19123431

53. Van Laar M, Pergolizzi JV, Mellinghoff HU, Merchante IM, Nalamachu S, O’Brien J, et al. Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J. 2012;6:320–30. doi: 10.2174/1874312901206010320 23264838

54. Cramer JA, Mintzer S, Wheless J, Mattson RH. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev Neurother. 2010;10:885–91. doi: 10.1586/ern.10.71 20518605

55. Pellock JM. Treatment considerations: traditional antiepileptic drugs. Epilepsy Behav. 2002;3:18–23. doi: 10.1016/S1525-5050(02)00538-3 12609308

56. Salmun LM, Gates D, Scharf M, Greiding L, Ramon F, Heithoff K. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. Clin Ther. 2000;22:573–82. doi: 10.1016/S0149-2918(00)80045-4 10868555

57. Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with “non-sedating” antihistamines: four prescription-event monitoring studies in general practice. BMJ. 2000;320:1184–6. 10784544

58. Rossat A, Fantino B, Bongue B, Colvez A, Nitenberg C, Annweiler C, et al. Association between benzodiazepines and recurrent falls: a cross-sectional elderly population-based study. J Nutr Health Aging. 2011;15:72–7. 21267523

59. Dommes A, Cavallo V. The role of perceptual, cognitive, and motor abilities in street-crossing decisions of young and older pedestrians. Ophthalmic Physiol Opt. 2011;31:292–301. doi: 10.1111/j.1475-1313.2011.00835.x 21470273